{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:06:34Z","timestamp":1775653594225,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47357-1","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T06:38:49Z","timestamp":1775543929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of residual kidney function in chronic hemodialysis patients using plasma metabolomics"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3841-3049","authenticated-orcid":false,"given":"David A.","family":"Jaques","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Boccard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriane","family":"Strassel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Ana\u00efs","family":"Monat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioele","family":"Visconti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Jotterand Drepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Marangon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Saudan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"De Seigneux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Rudaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belen","family":"Ponte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"47357_CR1","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","volume":"96","author":"KJ Jager","year":"2019","unstructured":"Jager, K. J. et al. A single number for advocacy and communication\u2014Worldwide more than 850 million individuals have kidney diseases. Kidney Int. 96, 1048\u20131050 (2019).","journal-title":"Kidney Int."},{"key":"47357_CR2","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/ndt\/gfac165","volume":"38","author":"JA Huijben","year":"2022","unstructured":"Huijben, J. A. et al. Increasing numbers and improved overall survival of patients on kidney replacement therapy over the last decade in Europe: An ERA Registry study. Nephrol. Dial. Transplant. 38, 1027\u20131040 (2022).","journal-title":"Nephrol. Dial. Transplant."},{"key":"47357_CR3","doi-asserted-by":"publisher","first-page":"sfae405","DOI":"10.1093\/ckj\/sfae405","volume":"18","author":"R Boenink","year":"2025","unstructured":"Boenink, R. et al. The ERA Registry Annual Report 2022: Epidemiology of Kidney Replacement Therapy in Europe, with a focus on sex comparisons. Clin. Kidney J. 18, sfae405 (2025).","journal-title":"Clin. Kidney J."},{"key":"47357_CR4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1053\/j.ajkd.2010.03.020","volume":"56","author":"T Shafi","year":"2010","unstructured":"Shafi, T. et al. Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am. J. Kidney Dis. Off. J. Natl. Kidney Found. 56, 348\u2013358 (2010).","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"47357_CR5","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1681\/ASN.2015101142","volume":"27","author":"Y Obi","year":"2016","unstructured":"Obi, Y. et al. Residual kidney function decline and mortality in incident hemodialysis patients. J. Am. Soc. Nephrol. 27, 3758\u20133768 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"47357_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.ajkd.2016.08.030","volume":"69","author":"MMY Wong","year":"2017","unstructured":"Wong, M. M. Y. et al. Interdialytic weight gain: Trends, predictors, and associated outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS). Am. J. Kidney Dis. 69, 367\u2013379 (2017).","journal-title":"Am. J. Kidney Dis."},{"key":"47357_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1681\/ASN.2005020132","volume":"17","author":"AK Cheung","year":"2006","unstructured":"Cheung, A. K. et al. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J. Am. Soc. Nephrol. JASN 17, 546\u2013555 (2006).","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"47357_CR8","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1681\/ASN.2018010081","volume":"29","author":"SC Leong","year":"2018","unstructured":"Leong, S. C. et al. Residual function effectively controls plasma concentrations of secreted solutes in patients on twice weekly hemodialysis. J. Am. Soc. Nephrol. 29, 1992 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"47357_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2215\/CJN.03170707","volume":"3","author":"CW McIntyre","year":"2008","unstructured":"McIntyre, C. W. et al. Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin. J. Am. Soc. Nephrol. 3, 19\u201326 (2008).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"47357_CR10","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1681\/ASN.2018121194","volume":"30","author":"R Marants","year":"2019","unstructured":"Marants, R., Qirjazi, E., Grant, C. J., Lee, T.-Y. & McIntyre, C. W. Renal perfusion during hemodialysis: Intradialytic blood flow decline and effects of dialysate cooling. J. Am. Soc. Nephrol. 30, 1086\u20131095 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"47357_CR11","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1681\/ASN.2017101088","volume":"29","author":"HA Polinder-Bos","year":"2018","unstructured":"Polinder-Bos, H. A. et al. Hemodialysis induces an acute decline in cerebral blood flow in elderly patients. J. Am. Soc. Nephrol. JASN 29, 1317\u20131325 (2018).","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"47357_CR12","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1093\/ndt\/gfac205","volume":"37","author":"DA Jaques","year":"2022","unstructured":"Jaques, D. A. et al. Outcomes of incident patients treated with incremental haemodialysis as compared with standard haemodialysis and peritoneal dialysis. Nephrol. Dial. Transplant. 37, 2514\u20132521 (2022).","journal-title":"Nephrol. Dial. Transplant."},{"key":"47357_CR13","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1681\/ASN.2009111132","volume":"21","author":"EP Rhee","year":"2010","unstructured":"Rhee, E. P. et al. Metabolite profiling identifies markers of uremia. J. Am. Soc. Nephrol. JASN 21, 1041\u20131051 (2010).","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"47357_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2215\/CJN.05540512","volume":"8","author":"VO Shah","year":"2013","unstructured":"Shah, V. O. et al. Plasma metabolomic profiles in different stages of CKD. Clin. J. Am. Soc. Nephrol. CJASN 8, 363\u2013370 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"47357_CR15","doi-asserted-by":"publisher","first-page":"19502","DOI":"10.1038\/s41598-020-76524-1","volume":"10","author":"Y Gagnebin","year":"2020","unstructured":"Gagnebin, Y. et al. Exploring blood alterations in chronic kidney disease and haemodialysis using metabolomics. Sci. Rep. 10, 19502 (2020).","journal-title":"Sci. Rep."},{"key":"47357_CR16","first-page":"530","volume":"33","author":"Y Obi","year":"2018","unstructured":"Obi, Y., Kalantar-Zadeh, K., Streja, E. & Daugirdas, J. T. Prediction equation for calculating residual kidney urea clearance using urine collections for different hemodialysis treatment frequencies and interdialytic intervals. Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc. 33, 530\u2013539 (2018).","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc."},{"key":"47357_CR17","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1053\/j.ajkd.2015.07.015","volume":"66","author":"National Kidney Foundation","year":"2015","unstructured":"National Kidney Foundation. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. Am. J. Kidney Dis. Off. J. Natl. Kidney Found. 66, 884\u2013930 (2015).","journal-title":"Am. J. Kidney Dis. Off. J. Natl. Kidney Found."},{"key":"47357_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/ajcn\/33.1.27","volume":"33","author":"PE Watson","year":"1980","unstructured":"Watson, P. E., Watson, I. D. & Batt, R. D. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am. J. Clin. Nutr. 33, 27\u201339 (1980).","journal-title":"Am. J. Clin. Nutr."},{"key":"47357_CR19","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/ndt\/gfs115","volume":"28","author":"JT Daugirdas","year":"2013","unstructured":"Daugirdas, J. T. et al. Improved equation for estimating single-pool Kt\/V at higher dialysis frequencies. Nephrol. Dial. Transplant. 28, 2156\u20132160 (2013).","journal-title":"Nephrol. Dial. Transplant."},{"key":"47357_CR20","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1038\/ki.1996.534","volume":"50","author":"JE Tattersall","year":"1996","unstructured":"Tattersall, J. E., DeTakats, D., Chamney, P., Greenwood, R. N. & Farrington, K. The post-hemodialysis rebound: Predicting and quantifying its effect on Kt\/V. Kidney Int. 50, 2094\u20132102 (1996).","journal-title":"Kidney Int."},{"key":"47357_CR21","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.0894-0959.2004.17212.x","volume":"17","author":"JK Leypoldt","year":"2004","unstructured":"Leypoldt, J. K., Jaber, B. L. & Zimmerman, D. L. Daily hemodialysis\u2014selected topics: Predicting treatment dose for novel therapies using urea standard Kt\/V. Semin. Dial. 17, 142\u2013145 (2004).","journal-title":"Semin. Dial."},{"key":"47357_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/toxins10010033","volume":"10","author":"R Vanholder","year":"2018","unstructured":"Vanholder, R., Pletinck, A., Schepers, E. & Glorieux, G. Biochemical and clinical impact of organic uremic retention solutes: A comprehensive update. Toxins 10, 33 (2018).","journal-title":"Toxins"},{"key":"47357_CR23","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.2215\/CJN.01430121","volume":"16","author":"LL Ganesan","year":"2021","unstructured":"Ganesan, L. L. et al. Association of plasma uremic solute levels with residual kidney function in children on peritoneal dialysis. Clin. J. Am. Soc. Nephrol. CJASN 16, 1531\u20131538 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol. CJASN"},{"key":"47357_CR24","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.clinbiochem.2010.06.008","volume":"43","author":"K Pawlak","year":"2010","unstructured":"Pawlak, K., Kowalewska, A., Mysliwiec, M. & Pawlak, D. 3-Hydroxyanthranilic acid is independently associated with monocyte chemoattractant protein-1 (CCL2) and macrophage inflammatory protein-1beta (CCL4) in patients with chronic kidney disease. Clin. Biochem. 43, 1101\u20131106 (2010).","journal-title":"Clin. Biochem."},{"key":"47357_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57\u201363 (2011).","journal-title":"Nature"},{"key":"47357_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jchromb.2019.03.031","volume":"1116","author":"Y Gagnebin","year":"2019","unstructured":"Gagnebin, Y. et al. Toward a better understanding of chronic kidney disease with complementary chromatographic methods hyphenated with mass spectrometry for improved polar metabolome coverage. J. Chromatogr. B. 1116, 9\u201318 (2019).","journal-title":"J. Chromatogr. B."},{"key":"47357_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-023-02020-y","volume":"19","author":"E Olesti","year":"2023","unstructured":"Olesti, E. et al. Low-polarity untargeted metabolomic profiling as a tool to gain insight into seminal fluid. Metabolomics 19, 53 (2023).","journal-title":"Metabolomics"},{"key":"47357_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.semnephrol.2014.02.010","volume":"34","author":"R Masereeuw","year":"2014","unstructured":"Masereeuw, R. et al. The kidney and uremic toxin removal: Glomerulus or tubule?. Semin. Nephrol. 34, 191\u2013208 (2014).","journal-title":"Semin. Nephrol."},{"key":"47357_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12040234","volume":"12","author":"MK van Gelder","year":"2020","unstructured":"van Gelder, M. K. et al. Protein-bound uremic toxins in hemodialysis patients relate to residual kidney function, are not influenced by convective transport, and do not relate to outcome. Toxins 12, 234 (2020).","journal-title":"Toxins"},{"key":"47357_CR30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12967-024-05004-1","volume":"22","author":"Y Ren","year":"2024","unstructured":"Ren, Y. et al. Altered gut mycobiome in patients with end-stage renal disease and its correlations with serum and fecal metabolomes. J. Transl. Med. 22, 202 (2024).","journal-title":"J. Transl. Med."},{"key":"47357_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/j.jrn.2008.10.014","volume":"19","author":"G Muteliefu","year":"2009","unstructured":"Muteliefu, G., Enomoto, A. & Niwa, T. Indoxyl sulfate promotes proliferation of human aortic smooth muscle cells by inducing oxidative stress. J. Ren. Nutr. 19, 29\u201332 (2009).","journal-title":"J. Ren. Nutr."},{"key":"47357_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1159\/000299798","volume":"31","author":"Z Tumur","year":"2010","unstructured":"Tumur, Z., Shimizu, H., Enomoto, A., Miyazaki, H. & Niwa, T. Indoxyl sulfate upregulates expression of ICAM-1 and MCP-1 by oxidative stress-induced NF-kappaB activation. Am. J. Nephrol. 31, 435\u2013441 (2010).","journal-title":"Am. J. Nephrol."},{"key":"47357_CR33","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/ndt\/gfz042","volume":"35","author":"SM Toth-Manikowski","year":"2019","unstructured":"Toth-Manikowski, S. M. et al. Contribution of \u2018clinically negligible\u2019 residual kidney function to clearance of uremic solutes. Nephrol. Dial. Transplant. 35, 846\u2013853 (2019).","journal-title":"Nephrol. Dial. Transplant."},{"key":"47357_CR34","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1093\/ndt\/gfn739","volume":"24","author":"JC Schefold","year":"2009","unstructured":"Schefold, J. C. et al. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: A possible link between chronic inflammation and uraemic symptoms. Nephrol. Dial. Transplant. 24, 1901\u20131908 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"47357_CR35","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.ijcard.2012.12.090","volume":"168","author":"G Sulo","year":"2013","unstructured":"Sulo, G. et al. Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study. Int. J. Cardiol. 168, 1435\u20131440 (2013).","journal-title":"Int. J. Cardiol."},{"key":"47357_CR36","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1046\/j.1365-2362.2003.01186.x","volume":"33","author":"B Wirleitner","year":"2003","unstructured":"Wirleitner, B. et al. Immune activation and degradation of tryptophan in coronary heart disease. Eur. J. Clin. Invest. 33, 550\u2013554 (2003).","journal-title":"Eur. J. Clin. Invest."},{"key":"47357_CR37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2478\/v10039-010-0015-6","volume":"55","author":"K Pawlak","year":"2010","unstructured":"Pawlak, K., My\u015bliwiec, M. & Pawlak, D. Kynurenine pathway - A new link between endothelial dysfunction and carotid atherosclerosis in chronic kidney disease patients. Adv. Med. Sci. 55, 196\u2013203 (2010).","journal-title":"Adv. Med. Sci."},{"key":"47357_CR38","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/ckj\/sfaa031","volume":"14","author":"VC Konje","year":"2021","unstructured":"Konje, V. C. et al. Tryptophan levels associate with incident cardiovascular disease in chronic kidney disease. Clin. Kidney J. 14, 1097\u20131105 (2021).","journal-title":"Clin. Kidney J."},{"key":"47357_CR39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/bph.16219","volume":"181","author":"H Miao","year":"2024","unstructured":"Miao, H. et al. Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites. Br. J. Pharmacol. 181, 162\u2013179 (2024).","journal-title":"Br. J. Pharmacol."},{"key":"47357_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41392-024-01913-1","volume":"9","author":"H Miao","year":"2024","unstructured":"Miao, H. et al. Targeting Lactobacillus johnsonii to reverse chronic kidney disease. Signal Transduct. Target. Ther. 9, 195 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"47357_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41387-024-00315-0","volume":"14","author":"Q Zhang","year":"2024","unstructured":"Zhang, Q. et al. Metabolomic profiling reveals the step-wise alteration of bile acid metabolism in patients with diabetic kidney disease. Nutr. Diabetes 14, 85 (2024).","journal-title":"Nutr. Diabetes"},{"key":"47357_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1406690","volume":"15","author":"L Gan","year":"2024","unstructured":"Gan, L., Wang, L., Li, W., Zhang, Y. & Xu, B. Metabolomic profile of secondary hyperparathyroidism in patients with chronic kidney disease stages 3\u20135 not receiving dialysis. Front. Endocrinol. 15, 1406690 (2024).","journal-title":"Front. Endocrinol."},{"key":"47357_CR43","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1093\/ndt\/gfaa220","volume":"35","author":"FG Casino","year":"2020","unstructured":"Casino, F. G. et al. The reasons for a clinical trial on incremental haemodialysis. Nephrol. Dial. Transplant. 35, 2015\u20132019 (2020).","journal-title":"Nephrol. Dial. Transplant."},{"key":"47357_CR44","first-page":"182","volume":"32","author":"FG Casino","year":"2017","unstructured":"Casino, F. G. & Basile, C. The variable target model: A paradigm shift in the incremental haemodialysis prescription. Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc. 32, 182\u2013190 (2017).","journal-title":"Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. - Eur. Ren. Assoc."},{"key":"47357_CR45","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000104870","volume":"25","author":"AC Fry","year":"2007","unstructured":"Fry, A. C., Singh, D. K., Chandna, S. M. & Farrington, K. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Blood Purif. 25, 295\u2013302 (2007).","journal-title":"Blood Purif."},{"key":"47357_CR46","doi-asserted-by":"publisher","first-page":"316","DOI":"10.11613\/BM.2013.038","volume":"23","author":"M Miler","year":"2013","unstructured":"Miler, M. & Simundi\u0107, A.-M. Low level of adherence to instructions for 24-hour urine collection among hospital outpatients. Biochem. Med. 23, 316\u2013320 (2013).","journal-title":"Biochem. Med."},{"key":"47357_CR47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s40620-020-00906-x","volume":"34","author":"DA Jaques","year":"2021","unstructured":"Jaques, D. A. & Davenport, A. Serum \u03b22-microglobulin as a predictor of residual kidney function in peritoneal dialysis patients. J. Nephrol. 34, 473\u2013481 (2021).","journal-title":"J. Nephrol."},{"key":"47357_CR48","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.kint.2015.10.011","volume":"89","author":"T Shafi","year":"2016","unstructured":"Shafi, T. et al. Estimating residual kidney function in dialysis patients without urine collection. Kidney Int. 89, 1099\u20131110 (2016).","journal-title":"Kidney Int."},{"key":"47357_CR49","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.kint.2015.12.042","volume":"89","author":"J Wong","year":"2016","unstructured":"Wong, J. et al. Predicting residual kidney function in hemodialysis patients using serum \u03b2-trace protein and \u03b22-microglobulin. Kidney Int. 89, 1090\u20131098 (2016).","journal-title":"Kidney Int."},{"key":"47357_CR50","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1021\/acs.analchem.4c05018","volume":"97","author":"R Mandal","year":"2025","unstructured":"Mandal, R. et al. Comprehensive, quantitative analysis of SRM 1950: The NIST human plasma reference material. Anal. Chem. 97, 667\u2013675 (2025).","journal-title":"Anal. Chem."},{"key":"47357_CR51","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41592-021-01197-1","volume":"18","author":"S Alseekh","year":"2021","unstructured":"Alseekh, S. et al. Mass spectrometry-based metabolomics: A guide for annotation, quantification and best reporting practices. Nat. Methods. 18, 747\u2013756 (2021).","journal-title":"Nat. Methods."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47357-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47357-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47357-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:03:45Z","timestamp":1775649825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47357-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47357"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47357-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11701"}}